
Healthcare & Pharmaceuticals · BSE
Cian Healthcare Limited, incorporated in 2003, is a multinational manufacturing company certified by WHO-GMP and ISO 9001:2015, specializing in food supplements, sexual wellness, cosmeceuticals, nutraceuticals, ayurvedic, and pharmaceutical products. The company develops, manufactures, and commercializes products across 12 therapeutic divisions and 10 sales divisions, operating under its own brand while also engaging in government supplies, exports, and third-party manufacturing. Its product portfolio includes sachets, gels, lotions, creams, ointments, liquid orals, capsules, and tablets, and it holds a special license to manufacture veterinary products such as Venky's and SAVAvet. As of March 31, 2018, sales were comprised of 37% contract manufacturing, 24% government supplies, 23% franchise business, and 16% export sales.
Price Band
₹61 – ₹65
Issue Size
₹38.00 Cr
Lot Size
2000 shares
GMP
Est. Listing
₹65
at current GMP
Subscribed
—
Open
2 May 2019
Close
15 May 2019
Allotment
20 May 2019
Refund
21 May 2019
Demat Credit
22 May 2019
Listing
23 May 2019
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹65
Band: ₹61 – ₹65
Estimated Listing Price
₹65
Upper price + GMP
Lot Size
2000 shares
Min investment ₹1,30,000
Estimated Profit / Lot
₹0
2000 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹65 |
| 30 Oct 2026 | — | 0.0% | ₹65 |
| 29 Oct 2026 | — | 0.0% | ₹65 |
GMP is unofficial market data. Not a guarantee of listing performance.
Cian Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹38 Crores. The shares are offered at a price band of ₹61 to ₹65 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 2000 shares (approx. ₹1,30,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2019-05-22, while un-allotted funds or UPI block mandates will be released on 2019-05-21.
The latest grey market premium for Cian Healthcare Limited IPO is ₹0, which indicates an expected listing price of ₹65.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.